欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Chromatin/Epigenetic > RG2833

浏览历史

S80176

RG2833

MedMol 99%
  • 英文名:
  • RG2833
  • 别名:
  • N-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide; UNII-17V14R89EU; RGFP 109; RG2833 (RGFP109); S7292; RG-2833;
  • CAS号:
  • 1215493-56-3
  • 分子式:
  • C20H25N3O2
  • 分子量:
  • 339.43
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
MedMol S80176-5mg 99% ¥190.00元 6 - - - EA 加入购物车
MedMol S80176-10mg 99% ¥315.00元 7 - - - EA 加入购物车
MedMol S80176-25mg 99% ¥612.00元 6 - - - EA 加入购物车
MedMol S80176-50mg 99% ¥850.00元 5 - - - EA 加入购物车
源叶(MedMol) S80176-100mg 99% ¥1360.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: RG2833 is a brain-penetrant HDAC inhibitor with IC50s of 60 nM and 50 nM for HDAC1 and HDAC3, respectively. The Ki values for HDAC1 and HDAC3 are 32 and 5 nM, respectively
  • 靶点: HDAC3:50 nM (IC50);HDAC1:60 nM (IC50);HDAC1:32 nM (Ki);HDAC3:5 nM (Ki);HDAC
  • 体内研究:
    RG2833 (150 mg/kg) is able to correct frataxin deficiency in the brain and heart of KIKI mice 24 hours after a single injection, but not when lower doses are used. When followed in time, the frataxin mRNA increase induced by RG2833 in the KIKI mouse can be first detected at 12 hours and reach a maximum at 24 hours in both brain and heart. RG2833 (100 mg/kg, s.c.) is well tolerated in chronic dosing of mice without toxicity. RG2833 improves motor coordination of YG8R FRDA mice. RG2833 increases frataxin protein expression in the brain of YG8R FRDA mice. RGFP109 (30 mg/kg, p.o. once daily for 6 days) has no acute effects on dyskinesia after single or 6 days once-daily treatment. One week following cessation of RGFP109, dyskinesia and duration of ON-time with disabling dyskinesia are reduced by 37% and 50%, respectively
  • 参考文献:
    1. Rai M, et al. Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model. PLoS One. 2010, 5(1), e8825. 2. Sandi C, et al. Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model. Neurobiol Dis. 2011, 42(3), 496-505. 3. Johnston TH, et al. RGFP109, a histone deacetylase inhibitor attenuates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept study. Parkinsonism Relat Disord. 2013, 19(2), 260-264.
  • 溶解性: DMSO  :  ≥  50  mg/mL  (147.31  mM)
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.946 ml 14.731 ml 29.461 ml
    5 mM 0.589 ml 2.946 ml 5.892 ml
    10 mM 0.295 ml 1.473 ml 2.946 ml
    50 mM 0.059 ml 0.295 ml 0.589 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。